Skip to main content
Premium Trial:

Request an Annual Quote

Nitto Denko Acquires Avecia Biotechnology

Premium

Japan's Nitto Denko said this week that it has acquired Massachusetts-based nucleic acid manufacturer Avecia Biotechnology.

Terms of the acquisition were not disclosed.

The deal, Nitto Denko said, represents “a significant commitment … to the nucleic acids drug industry.” The company recently forged a collaboration with Quark Pharmaceuticals to develop siRNA-based drugs for fibrotic diseases (GSN 7/15/2010).

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.